tebu-bio is pleased to introduce a brand new cell line to assist researchers in the fight against COVID-19.

These cell lines are now available through the Japanese Collection of Research Bioresources (JCRB) cell bank. As the new exclusive provider of JCRB’s extensive resource catalogue to European customers, tebu-bio offers access to over 1 300 unique cell lines suitable to many different fields of research.

I invite you to discover an overview of these new JCRB cell lines associated with COVID-19 research in this post.

Researchers have shown that proteases are actively used by SARS-CoV-2 for it’s entry and replication into human cells. To support research on this topic, tebu-bio provides a full range of screening kits to identify inhibitory compounds directed against these human and viral proteases .

To better understand the mechanism of SARS-CoV-2 cell entry, BPS Bioscience have developed 3 new pseudotyped lentiviruses, allowing you to study the interaction between the coronavirus Spike protein and the human ACE2 protein in a physiologically relevant context.

One of the challenges in respiratory research in general, and for COVID-19 related projects in particular, is to have access to relevant in vitro cell culture models. Human lung epithelium models are currently being tested as a platform for COVID-19 research and several cell types susceptible to SARS-CoV infection have already been identified. In this post, I’ll introduce lung primary cell models you may find useful, as well as other cell types that have been reported as involved in COVID-19 infections and the multiple severe associated syndromes.